bf/NASDAQ:CADL_icon.jpeg

NASDAQ:CADL

Candel Therapeutics

  • Stock

USD

Last Close

4.94

06/11 22:19

Market Cap

178.24M

Beta: -

Volume Today

874.73K

Avg: 28.77K

PE Ratio

−2.46

PFCF: −1.09

OverviewFinancialsAPI

    Description

    Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as wel...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.8-0.6-0.4-0.20.20.42020-03-302020-12-302021-12-312022-12-312024-05-09

    Revenue (Estimate*)

    5K10K15K20K25K30K35K2020-03-302020-12-302021-12-312022-12-312024-05-09

    *Estimate based on analyst consensus